128 related articles for article (PubMed ID: 21783361)
1. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
[TBL] [Abstract][Full Text] [Related]
2. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
Zhang X; Hufnagel H; Hou C; Opas E; McKenney S; Crysler C; O'Neill J; Johnson D; Sui Z
Bioorg Med Chem Lett; 2011 Oct; 21(20):6042-8. PubMed ID: 21917454
[TBL] [Abstract][Full Text] [Related]
4. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
[TBL] [Abstract][Full Text] [Related]
5. Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc.
Price DA; Armour D; de Groot M; Leishman D; Napier C; Perros M; Stammen BL; Wood A
Bioorg Med Chem Lett; 2006 Sep; 16(17):4633-7. PubMed ID: 16782336
[TBL] [Abstract][Full Text] [Related]
6. Identification of a sulfonamide series of CCR2 antagonists.
Peace S; Philp J; Brooks C; Piercy V; Moores K; Smethurst C; Watson S; Gaines S; Zippoli M; Mookherjee C; Ife R
Bioorg Med Chem Lett; 2010 Jul; 20(13):3961-4. PubMed ID: 20627722
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.
Yun J; Han M; Song C; Cheon SH; Choi K; Hahn HG
Bioorg Med Chem Lett; 2014 Aug; 24(15):3234-7. PubMed ID: 24974340
[TBL] [Abstract][Full Text] [Related]
8. A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Subasinghe NL; Lanter J; Markotan T; Opas E; McKenney S; Crysler C; Hou C; O'Neill J; Johnson D; Sui Z
Bioorg Med Chem Lett; 2013 Feb; 23(4):1063-9. PubMed ID: 23294701
[TBL] [Abstract][Full Text] [Related]
9. 4-Azetidinyl-1-heteroatom linked cyclohexane antagonists of CCR2: patent evaluation.
Horuk R; Guilford W
Expert Opin Ther Pat; 2011 Aug; 21(8):1275-80. PubMed ID: 21554155
[TBL] [Abstract][Full Text] [Related]
10. 2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.
Slee DH; Moorjani M; Zhang X; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Jalali K; Sai Y; Zuo Z; Yang C; Wen J; O'Brien Z; Petroski R; Saunders J
J Med Chem; 2008 Mar; 51(6):1730-9. PubMed ID: 18307293
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Mo R; Meyer DT; Pechulis AD; Guaciaro MA; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Cvijic ME; Barrish JC; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2012 Oct; 22(19):6181-4. PubMed ID: 22939233
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.
Kasai S; Kamata M; Masada S; Kunitomo J; Kamaura M; Okawa T; Takami K; Ogino H; Nakano Y; Ashina S; Watanabe K; Kaisho T; Imai YN; Ryu S; Nakayama M; Nagisa Y; Takekawa S; Kato K; Murata T; Suzuki N; Ishihara Y
J Med Chem; 2012 May; 55(9):4336-51. PubMed ID: 22490048
[TBL] [Abstract][Full Text] [Related]
13. Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.
Ducray R; Jones CD; Jung FH; Simpson I; Curwen J; Pass M
Bioorg Med Chem Lett; 2011 Aug; 21(16):4702-4. PubMed ID: 21764307
[TBL] [Abstract][Full Text] [Related]
14. Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors.
Giordanetto F; Knerr L; Selmi N; Llinàs A; Lindqvist A; Wang QD; Ståhlberg P; Thorstensson F; Ullah V; Nilsson K; O'Mahony G; Högberg G; Lindhardt E; Strand A; Duker G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5557-61. PubMed ID: 21782423
[TBL] [Abstract][Full Text] [Related]
15. Substituted dipiperidine alcohols as potent CCR2 antagonists.
Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.
Roughley SD; Browne H; Macias AT; Benwell K; Brooks T; D'Alessandro J; Daniels Z; Dugdale S; Francis G; Gibbons B; Hart T; Haymes T; Kennett G; Lightowler S; Matassova N; Mansell H; Merrett A; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Simmonite H; Tan K; Walls SB; Wong M
Bioorg Med Chem Lett; 2012 Jan; 22(2):901-6. PubMed ID: 22209458
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
[TBL] [Abstract][Full Text] [Related]
18. Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists.
Berlin M; Lee YJ; Boyce CW; Wang Y; Aslanian R; McCormick KD; Sorota S; Williams SM; West RE; Korfmacher W
Bioorg Med Chem Lett; 2010 Apr; 20(7):2359-64. PubMed ID: 20188550
[TBL] [Abstract][Full Text] [Related]
19. Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists.
Pasternak A; Goble SD; Vicario PP; Di Salvo J; Ayala JM; Struthers M; DeMartino JA; Mills SG; Yang L
Bioorg Med Chem Lett; 2008 Feb; 18(3):994-8. PubMed ID: 18164199
[TBL] [Abstract][Full Text] [Related]
20. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
